ipam

FLB-457 is a dopamine antagonist.

Etripamil (MSP-2017) 是一种短效L 型钙通道拮抗剂，可用于治疗阵发性室上性心动过速的研究。它通过抑制房室结细胞中钙慢通道的钙离子流入，显示房室结传导并延长房室结不应期

Fipamezole 是一种有效的 α2肾上腺素能受体拮抗剂，可能用于研究帕金森病自主神经功能障碍。

Iodipamide (Iodipamic acid) 是一种三碘苯甲酸酯衍生物，也是一种离子二聚剂，可用于诊断成像。

Atipamezole hydrochloride (MPV-1248 hydrochloride) 是一种 α2-肾上腺素受体拮抗剂，Ki=1.6 nM。

Ecopipam (UNII-0X748O646K) 是一种有效的、选择性、具有口服活性的多巴胺 D1 D5 受体拮抗剂，Ki 值分别为 1.2 nM 和 2.0 nM。Ecopipam 对 D2、D4、5-HT 和 α2a 受体 (Ki=0.98，5.52，0.08 和 0.73 μM) 显示出超过 40 倍的选择性。Ecopipam 可用于精神分裂症、可卡因成瘾和肥胖症的研究。

Adipamidoxime (NSC-70868) 是一种肟类活性化合物，可以抑制某些细菌、真菌和病毒的生长，并具有一些抗炎和抗肿瘤活性。

Odapipam is a selective and high affinity antagonist of benzazepine dopamine D1 receptor (Kd of 0.18 nM).

Pipamperone (McN-JR 3345) 是5-HT2A 受体和D4受体的高亲和力拮抗剂，也是D2受体的低亲和力拮抗剂，pKi 分别为 8.2、8.0 和 6.7。

Anipamil is a long-acting blocker of calcium channel,and for the treatment of cardiovascular disease.

Xipamide (Diurexan) 是一种磺胺类利尿剂，具有抗高血压特性。Xipamide 可选择性地抑制阴离子交换器。

Etripamil (MSP-2017) hydrochloride 是一种短效的 L-型钙通道拮抗剂，用于研究阵发性室上性心动过速 (PSVT)。它通过抑制钙离子慢通道来阻止钙离子流入，从而减缓房室结传导并延长房室结不应期。

Ronipamil is an analogue of verapamil that used as a calcium entry blocker.

Falipamil is a verapamil derivative and a calcium channel antagonist. Falipamil exerts antitachycardic effects by a direct action on the sinus node. Falipamil decreases HR at exercise in normal subjects and may exert antianginal effects in patients with m

Fipamezole HCl, a α2-adrenoceptor antagonist, is used potentially for the treatment of dyskinesia associated with Parkinson's disease.

Pipamperone acts as an antagonist of the 5-HT2A, 5-HT2B, 5-HT2C D2, D3, D4, α1-adrenergic, and α2-adrenergic receptors. It shows much higher affinity for the 5-HT2A and D4 receptors over the D2 receptor (15-fold in the case of the D4 receptor, and even hi

Alipamide is a bio-active chemical.

Tripamide is a type of diuretic.

Atipamezole (Antisedan) 是 α2-肾上腺素受体拮抗剂，Ki=1.6 nM。

Falipamil hydrochloride is a calcium channel antagonist potentially for the treatment of ischaemic heart disorder and sinus.

Berupipam is a dopamine D1 receptor antagonist.

Cipamfylline is a xanthine, a theophylline analogue, and is a potent and selective inhibitor of phosphodiesterase type 4 (PDE-4). Cipamfylline was tested in patients with a diagnosis of atopic dermatitis and in two human models of acute and chronic irritant contact dermatitis. The outcome of the study revealed that cipamfylline was more effective than vehicle in treating atopic dermatitis, but less effective than a group II steroid, hydrocortisone-17-butyrate both in the treatment of atopic dermatitis and irritant contact dermatitis. The absorption of cipamfylline and the subsequent systemic exposure might be the reason why further clinical studies with higher doses of cipamfylline have not been published.

Ecopipam (SCH 39166) hydrobromide 是一种高效、选择性的口服多巴胺D1 D5受体拮抗剂，其对D1和D5受体的Ki值分别为1.2 nM和2.0 nM。相比之下，它对D2、D4、5-HT及α2a受体（Ki分别为0.98、5.52、0.08及0.73 μM）的选择性超过40倍。Ecopipam hydrobromide主要用于精神分裂症和肥胖症的研究应用。

Ipamorelin (NNC-26-0161) 是一种生长激素释放肽，可诱导大鼠纵向骨生长。